HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models
暂无分享，去创建一个
P. Colombo | F. Penault-Llorca | N. Radosevic-Robin | B. Robert | C. Gongora | R. Bras-Gonçalves | H. Bazin | A. Pèlegrin | A. Savina | D. Azria | C. Mollevi | C. Larbouret | Y. Lazrek | T. Chardès | W. Leconet | N. Gaborit | Gaëlle Thomas | G. Thomas